baber/WOPTO huggingface dataset:
Patent JP-2001520579-A (JP)
Title: 段ボール製造プラント用の糊付機
IPC: B05C1/14
Filed: 1998-03-26
Abstract: (57)【要約】
本発明は、ペーパーシート、特にペーパーシートのコルゲートの側のコルゲートの先端に糊を塗布する為の方法に関するものであり、糊はペーパーシートの全幅にわたって延びるスクリーン(３０)、又は表面（９ａ）に肌理を持つエンドレスベルト（９）の表面、又は穴の中に施され、その長軸方向に走行するペーパーシート（５）の糊付けされる表面はスクリーン(３０)、又はエンドレスベルト（９）の表面上の、又は穴の中の糊と接触する。エンドレステープ、又はエンドレススクリーンから糊付けされる可きシートへの直接の糊の受渡しの代わりに糊の塗布は先ず糊塗布エレメント上に行なわれ、このエレメントから次に糊付けされる可きシートに対して行なわれる。本発明は更に上記の方法を実施する為の糊付機に関するものである。
Patent JP-2001523101-A (JP)
Title: 殺菌剤耐性を得るための、植物における殺菌剤結合ポリペプチドの発現
IPC: A01H5/00
Filed: 1998-04-16
Abstract: (57)【要約】
植物において殺菌剤結合抗体を発現させることにより、殺菌剤耐性植物を製造するための方法。
Patent JP-2001522430-A (JP)
Title: エンジンにおけるクランク室の換気装置
IPC: F01M13/04
Filed: 1998-04-29
Abstract: (57)【要約】
回転するホイールまたはギヤが、それの遠心効果によって排出口付近の漏出ガス内の油滴を油霧から分離するように、駆動列（３，４，５）内に存在するホイールまたはギヤ（３）の一側面に配置される排出口（１３）を持つ、クランク室換気装置を有するエンジン。
Patent JP-2001521434-A (JP)
Title: 細胞処理システム
IPC: G01N33/48
Filed: 1998-05-20
Abstract: (57)【要約】
本発明は、無菌環境に維持された生物細胞を対話式に処理する方法又は装置である。更に、本発明は、Ａ、Ｂ又はＡＢ型の赤血球をＯ型に酵素的に変換する優れたシステムを提供する。無菌環境に維持された生物細胞を対話式に処理するシステム（１０）は、供給モジュール（２０）、細胞モジュール（１２）、処理モジュール（６０）、１組の導管、複数の弁、複数のセンサ及び１つの制御モジュール（８０）を含む。供給モジュールは、選択された量の処理化学物質を提供するよう構築され、配置される。細胞モジュールは、処理のために処理モジュールに供給された生物細胞の量を測定する細胞センサを含む。処理モジュールは、前記生物細胞を処理するよう構築され、配置される。数本の導管が、無菌的方法で供給モジュール、細胞モジュール及び処理モジュールを接続し、弁が、モジュール間の生物細胞及び処理化学物質の移送を制御する。センサは、導管内の生物細胞及び処理化学物質の移送を検出するよう構築され、配置される。制御モジュールは、弁、センサ及び処理モジュールと、動作可能な状態で接続される。制御モジュールは、細胞センサからのデータも受信し、細胞センサのデータに基づいて生物細胞の移送及び処理を制御する。システムは、処理される細胞のタイプ又は処理に提供される細胞の量に基づき、処理アルゴリズムを調節することができる。
Patent MD-20010231-A (MD)
Title: Rotor-type hydraulic motor
Inventor: ARSENE ION
IPC: F03B17/06
Filed: 2001-07-24
Abstract: The invention relates to the field of hydraulic power engineering and may be used for water power-to-electric power conversion. The rotor-type hydraulic motor includes a horizontal shaft, provided with a chain sprocket and disks uniformly fixed along its length, fastened by bearings and supports to the floating platform. The blades are provided with stiffening ribs, to which there are articulately fixed the cantilevers, one end of which is bent and the other one is rigidly fixed to the disks. Onto the cantilevers there are installed plastic elastic bearing pads for blades. With that, onto the floating platform there is installed an electric generator connected kinematically to the horizontal shaft by a chain transmission.Claims: 1Fig.: 2
Patent MD-20020015-A (MD)
Title: Balneal process of treatment of cardiovascular and locomotorium diseases
Inventor: ŞEPELI DIANA
IPC: A61P9/04
Filed: 2001-12-26
Abstract: The invention refers to medicine, in particular to balneology.Summary of the claimed process consists in that in the capacity of medicinal remedy is used comminuted sclary sage (Salvia sclarea) and brandy mint (Mentha piperita) in the ratio of 95:5.
Patent NZ-194113-A (NZ)
Title: Delignification process using nitroanthraquinone additives
Inventor: BLANK H
IPC: D21C3/22
Filed: 1980-06-23
Abstract: A process for delignifying lignocellulosic material with a digestion liquor of nitroanthraquinones and/or dinitroanthraquinones. The process can be carried out in a closed reaction vessel at temperatures of 150 DEG -200 DEG +/- C. for 0.5 to 480 minutes with 0.001 to 10% nitroanthraquinone and/or dinitroanthraquinone by weight of lignocellulosic material.
Patent NZ-200715-A (NZ)
Title: Acridine derivatives and pharmaceutical compositions containing such
Inventor: ATWELL G J
IPC: C07D219/10
Filed: 1982-05-24
Abstract: The novel class of compounds of the present invention represented by the general formula (I): 
<CHEM>
 A and B each represent H or a lower alkane optionally substituted with amino and/or hydroxyl functions, except that A and B are not both H;
 R3 represents H, OCH3, CH3, halogen, NH2, NO2, NHCH3, N3(CH3)2, N3, NHCOCH3, NHCOOCH3, N(CH3)COOCH3, CONH2 or CONHCH3, R4 represents H, alkyl, O-alkyl, CONH2, CONHCH3 or CONHCH2CONHCH3, except that R3 and R4 taken together can represent -C = CH -CN = N-;
 R5 represents H, alkyl, O-alkyl, CONH2, CONHCH3 or CONH2CH2 CONHCH3;
 R6 represents lower alkyl;
 R7 represents CH3 or C6H5 (phenyl);
 R8 represents lower alkyl or C6H5 (phenyl);
 R9 represents H, NHCOCH3, NH2 or N=CHN(CH3)2; and
 R10 represents H or NH2;
 and the acid addition salts thereof, possess antibacterial and antitumour properties.
Patent NZ-212177-A (NZ)
Title: Method and apparatus for transporting live fish
Inventor: JERRETT A R
IPC: G02B6/44
Filed: 1985-05-23
Abstract: A method of transporting live fish said method comprising the steps of inducing a state of piscine immobility syndrome, as herein defined, in said fish and maintaining said state while displacing the fish to the desired destination.
Patent NZ-213184-A (NZ)
Title: Combined hydrostatic/hydrodynamic bearing system for grinding apparatus
Inventor: REINHALL ROLF BERTIL
IPC: F16J10/02
Filed: 1985-08-21
Abstract: Combined hydrostatic/hydrodynamic bearing system for a grinding apparatus in which the material is ground in a grinding space defined between a pair of relatively rotating grinding members and in which at least one of the grinding members is carried by an axially displaceable rotatable shaft. One or more cylindrical pistons are mounted on the rotatable shaft to rotate therewith within a pressure chamber defined within a stationary cylindrical housing permitting the piston or pistons to be displaced axially therein. Fluctuations in axial thrust forces acting on the displaceable rotatable shaft are counteracted by applying a fluid pressure medium to one or both of the piston ends of the cylindrical piston or pistons in a controlled manner so as to maintain a predetermined clearance range of the grinding space.
Patent NZ-222304-A (NZ)
Title: Suppression of bone marrow using samarium-153, gadolinium-159 or holmium-166 complexes
Inventor: KAPLAN DONALD A
IPC: A61L27/00
Filed: 1987-10-27
Abstract: Bone marrow is suppressed by administering at least one bone marrow suppressing radionuclide composition having at least one of Samarium-153, Gadolinium-159, or Holmium-166 and at least one of ethylenediaminetetramethylenephosphonic acid, diethylenetriaminepentamethylenephosphonic acid, hydroxyethylethylenediaminetrimethylenephosphonic acid, nitrilotrimethylenephosphonic acid or tris(2-aminoethyl)aminehexamethylenephosphonic acid, or a physiologically-acceptable salt thereof.
Patent NZ-226370-A (NZ)
Title: Reduced calorie fat/triglyceride compositions; cooking oils or use in food
Inventor: YANG DAVID KEE
IPC: A23D7/00
Filed: 1988-09-28
Abstract: Reduced calorie edible fats and oils comprising triglycerides synthesized (tailored) with a particular combination of saturated medium chain fatty acids, saturated long chain fatty acids, and unsaturated long chain fatty acids are disclosed. In addition to providing caloric reduction, these tailored triglycerides also have acceptable autoignition characteristics making them suitable for use in shortenings and cooking oils.
Patent NZ-235908-A (NZ)
Title: A process for preparing the r or s enantiomer of 2,2-r 1 ,r 2 -1,3-dioxolane-4-carboxylic acid
Inventor: WALRAVEN HUBERTUS GERARDUS MAR
IPC: C07D317/72
Filed: 1990-10-31
Abstract: A process is disclosed for preparing a 2,2-R1,R2-1,3-dioxolane-4-carboxylic acid or salt thereof rich in either the R or S enantiomer which process comprises   a) preparing a solution which contains a non-racemic mixture of R and S enantiomer of a carboxylate of the formula <CHEM>  and M<n+> ions, wherein R1 and R2 are each, independently, H or an unsubstituted or substituted alkyl group, or R1 and R2, together with the carbon atom to which they are attached, form an unsubstituted or substituted carbocyclic ring, and M is an alkali metal, an alkaline earth metal, a group IIb metal, boron, or an ammonium, di- or tri-alkanolammonium ion having 2 or 3 carbon atoms or a tetra C1-C16 alkyl ammonium ion, and n is the valency of M;   b) reducing the solubility of the M<n+> salt of compound (I); and   c) separating the resulting crystals from the mother liquor. e
Patent NZ-236104-A (NZ)
Title: A device for transdermal delivery of an opiate antagonist for treatment of alcoholism
Inventor: SINCLAIR JOHN DAVID
IPC: A61K9/48
Filed: 1990-11-16
Abstract: The use of an opiate antagonist for the preparation of a pharmaceutical composition to be transdermally administered simultaneously or separately sequentially with alcohol and a device for transdermally administering the antagonist. The device is a package containing a fixed dose of opiate antagonist, a vehicle and a permeation enhancer.
Patent NZ-241865-A (NZ)
Title: Process for polymerising vinylcyclohexene and cyclopentadiene using an olefin metathesis catalyst
Inventor: KELSEY DONALD ROSS
IPC: C08G61/06
Filed: 1992-03-06
Abstract: A hard, infusible, crosslinked polymeric product free from detectable cyclopentadiene odor is obtained by contacting, under polymerization conditions, a mixture of Diels-Alder adducts of 4-vinylcyclohexene and cyclopentadiene and Diels-Alder oligomers of cyclopentadiene of at least 3 cyclopentadiene units with an olefin methathesis catalyst.
Patent NZ-244714-A (NZ)
Title: Process for preparing 7-aminocephalosporanic acid and 7-aminodeacetylcephalosporanic acid in an adipate feedstock
Inventor: CONDER MICHAEL J
IPC: C12P35/00
Filed: 1992-10-13
Abstract: Important intermediates for preparing cephalosporin antibiotics, 7-amino-cephalosporanic acid (7-ACA) and 7-aminodeacetylcephalosporanic acid (7-ADAC), are prepared by a novel bioprocess in which a transformed Penicillium chrysogenum strain is cultured in the presence of an adipate feedstock to produce adipoyl-6-APA (6-amino penicillanic acid); followed by the in situ expression of the following genes with which the P. chrysogenum has been transformed:   1) an expandase gene, e.g., from Cephalosporium acremonium, whose expression product converts the adipoyl-6-APA by ring expansion to adipoyl-7-ADCA; 2) an hydroxylase gene whose expression product converts the 3-methyl side chain of adipoyl-7-ADCA to 3-hydroxymethyl, to give the first product, adipoyl-7-aminodeacetylcephalosporanic acid (7-ADAC); and 3) an acetyltransferase gene whose expression product converts the 3-hydroxymethyl side chain to the 3-acetyloxymethyl side chain of adipoyl-7-ACA. The final product, 7-ACA, is then prepared by cleavage of the adipoyl side chain using an adipoyl acylase. The entire synthesis, accordingly, is carried out using bioprocesses, and is efficient and economical.
Patent NZ-255409-A (NZ)
Title: Microcapsules having an outer wall comprising both synthetic and biopolymer and which has site-, structure- or tissue-specific properties or having functional groups for binding metal complexes or their ligands or various sites
Inventor: FRITZSCH THOMAS
IPC: A61K49/00
Filed: 1993-09-08
Abstract: The invention concerns microparticle preparations made from biodegradable copolymers for therapeutic and diagnostic use, in particular for ultrasonic examinations, plus a method of producing such preparations.
Patent NZ-262612-A (NZ)
Title: Pigment and filler particles coated with an electric-charge-modifying agent and a dispersing agent
Inventor: SUPPLEE WILLIAM W
IPC: C09C1/24
Filed: 1994-02-08
Abstract: This invention relates to modifying the surface of particles for improved dispersion characteristics in aqueous, solvent, resinous, polymeric, cementitious or the like application systems. In particular, this invention relates to a pigment or filler particle whose surface is coated with at least one electric charge modifying agent and at least one dispersion promoting agent, which has improved dispersibility, coloring, handling, and other processing properties in application systems. The electric charge modifying agent may be selected from the group of Mg, Ca, Ba, Sr, Ti, V, Zr, Cr, Mn, Fe, Co, Ni, Cu, Zn, and Al. The dispersion promoting agent may be selected from the group of stearates, acetates, alkylphenols, cellulosics, waxes, lignins, polyacrylics, polyepoxies, polyurethanes, polyethylenes, polystyrenes and polypropylenes, and polymers having functional groups of alcohols, glycols, aldehydes, amides and carboxylic acids. Iron oxide is the preferred pigment particle.
Patent NZ-273242-A (NZ)
Title: Treatment of liver disease by administration of a vasodilator which increases the oxygen supply to the liver; pharmaceutical compositions
Inventor: MCLEAN ALLAN JOSEPH
IPC: A61P1/16
Filed: 1994-09-05
Abstract: A method for the treatment of liver disease selected from the group consisting of cirrhosis of the liver, toxic and medicamentary liver damage, a liver parenchymic disorder and hepatitis.  The method includes administering to a non-human or animal subject in need thereof a therapeutically active or prophylactically effective low dose amount of a vasodilating agent that selectively increases the supply of oxygenated blood to the liver by increasing hepatic arterial inflow.  The vasodilating agent is a calcium blocker, a derivative of benzothisaepine, see formula described, preferably nifedipine, felodipine or verapamil.
Patent NZ-286656-A (NZ)
Title: Pharmaceutical compositions comprising a forebrain selective NMDA antagonist and an excitatory feedback enhancing agent used in treating Parkinsons Disease
Inventor: CHENARD BERTRAND L
IPC: A61K31/195
Filed: 1996-05-24
Abstract: A pharmaceutical composition comprises a Parkinson's disease treating effective amount of a combination of a forebrain selective NMDA antagonist and an excitatory feedback enhancing agent with a pharmaceutically acceptable diluent or carrier and optionally carbidopa. The forebrain selective NMDA antagonist can be (+)-(1S,2S)-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol, (1S,2S)-1-(4-hydroxy-3-methoxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol and (3R,4S)-3-(4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl)-chroman-4,7-diol and the excitatory feedback enhancing agent is levodopa.
Patent NZ-323329-A (NZ)
Title: 4-phenyl-piperidin-1-yl butyric acid derivatives and medicaments
Inventor: HUPE DONALD
IPC: A61P1/02
Filed: 1996-11-27
Abstract: PCT No. PCT/US96/18925 Sec. 371 Date Jun. 8, 1998 Sec. 102(e) Date Jun. 8, 1998 PCT Filed Nov. 27, 1996 PCT Pub. No. WO97/23459 PCT Pub. Date Jul. 3, 1997Aromatic keto-acid compounds and derivatives are described as well as methods for the preparation and pharmaceutical compositions of same, which are useful as inhibitors of matrix metalloproteinases, particularly gelatinase A (72 kD gelatinase) and stromelysin-1 and for the treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, arthrities, or other autoimmune or inflammatory disorders dependent upon tissue invasion by leukocytes.
Patent NZ-323896-A (NZ)
Title: Process for the preparation of 1-aryl-1-cyanocyclobutane derivatives
Inventor: BARKER STEPHEN JOHN
IPC: C07C253/30
Filed: 1996-11-28
Abstract: process for the preparation of 1-aryl-1- cyanocyclobutane derivatives of formula III, wherein: R1 represents a halo R2 represents hydrogen or halo  The process of manufacturing said derivatives involves the reaction of a solution of a 1,3-dihalopropane and a cyanobenzyl derivative in a substantially dimethyl sulphoxide-free solvent with a suspension of a base in a substantially dimethyl sulphoxide-free solvent at a temperature of at least 35 C.
Patent NZ-332460-A (NZ)
Title: Portable sawmill arrangement facility for reassembly
Inventor: PETERSON CARL JAMES
IPC: B27B5/20
Filed: 1997-03-26
Abstract: A carriage is disclosed for a portable sawmill, the carriage comprising spaced apart end frames (8), a carriage deck (17) that is adapted to support a saw for movement therealong, bushes (18a,b) for connecting the carriage deck with uprights of the end frames and drive (16) for adjustably supporting the carriage deck for upward and downward movement relative to the uprights, separate supporting bushes (18a,b) being associated with each end frame, each bush (18a,b) being held in position on the respective end frame when the sawmill is disassembled for transportation.
Patent NZ-333386-A (NZ)
Title: Palladium-gold catalyst vinyl acetate production
Inventor: NICOLAU IOAN
IPC: B01J23/66
Filed: 1997-06-03
Abstract: Disclosed is a supported palladium-gold catalyst for vinyl acetate production from ethylene, acetic acid and oxygen. The reactants employed in the catalyst preparation are potassium salt compounds that are essentially sodium-free. A preferred invention palladium-gold catalyst provides exceptional improvement of carbon dioxide selectivity in vinyl acetate production. The process for preparing the catalyst comprises 1) impregnating a porous catalyst support medium with an aqueous solution consisting of water-soluble potassium-palladium compound and water-soluble potassium-gold compound; 2) precipitating water-insoluble palladium and gold compounds on the catalyst support surface with an aqueous solution of basic potassium salt fixing agent and 3) reducing the water insoluble palladium and gold compounds to palladium metal and gold metal.
Patent NZ-337968-A (NZ)
Title: Catalyst system containing a metallocene complex component, activator component and a support material component for high yield synthesis of polyolefins
Inventor: PEIL KEVIN P
IPC: C08F4/65
Filed: 1998-03-30
Abstract: The process is for the polymerization of an olefin monomer or an olefin monomer and one or more co-monomers to produce a polymer.  The process is carried out in a polymerization reactor in the presence of a supported olefin polymerization catalyst system produced from catalyst components comprising: a) a support material component comprising one or more dehydrated support materials; b) a metallocene complex component comprising one or more metallocene complexes used in a total loading range of from 0.1 to 25 mmol of metallocene complex/gram of support material component and c) an activator component comprising one or more activators used in a range of molar ratios of total moles of activator to total moles of metallocene complex of from 0.5 to 2.5 wherein  the catalyst system is used at a catalyst concentration in the range of from 0.01 x10-6 to 6 x 10-6 moles of active catalyst/mole of monomer and a catalyst efficiency results that is at least 2.4 x 107 g polymer/mole catalyst/hour.
Patent NZ-501342-A (NZ)
Title: Alkyl-4-silyl(furanyl or thienyl) phenols as antioxidant agents
Inventor: VAAL MARK J
IPC: A61P29/00
Filed: 1998-05-21
Abstract: Compounds of formula (1) are described wherein: R is hydrogen or -C(O)-(CH2)m-Q, wherein Q is hydrogen or -COOH and m is an integer 1, 2, 3 or 4; R1, R5 and R6 are independently a C1-C6 alkyl group; R2, R3 and R4 are independently hydrogen or a C1-C6 alkyl group; Z is thio, oxy or a methylene group; A is a C1-C4 alkylene group; X is thio or oxy; and G1 and G2 are independently hydrogen, C1-C6 alkyl or -C(O)-(CH2)n-CH3 an n is an integer 0, 1, 2 or 3; or a pharmaceutically acceptable salt thereof; useful for the treatment of atherosclerosis and chronic inflammatory disorders; for inhibiting cytokine-induced expression of VCAM-1 and/or ICAM-1; for inhibiting the peroxidation of LDL lipid; for lowering plasma cholesterol; and as anti-oxidant chemical additives useful for preventing oxidative deterioration in organic materials. The use of the compounds for treating chronic inflammatory diseases such as asthma, rheumatoid arthritis, autoimmune diabetes, transplant rejection, and tumour angiogenesis is also described.
Patent NZ-501988-A (NZ)
Title: Authentication of detected light intensity pattern using pixelwise comparison
Inventor: ATHERTON PETER SAMUEL
IPC: G06K5/00
Filed: 1996-08-06
Abstract: A method and apparatus for authenticating a light intensity pattern comprising an optical means for directing a pulsed light source at a diffracted image pattern at frame rate intervals, a sensor means to detect said diffracted image pattern on a pixel basis, a memory means for storing an authentic pattern in the format of a pixel array and a data processing means for receiving a detected pattern and for assigning the pixels on a pixel-by-pixel basis.
Patent NZ-502400-A (NZ)
Title: Derivatives of acyl-piperazinyl-pyrimidines
Inventor: FRIGOLA CONSTANSA JORDI
IPC: C07C231/00
Filed: 1998-07-21
Abstract: A derivative of acyl-piperazinyl-pyrimidine of formula (I) wherein: X is an oxygen or sulphur atom; R1 is an alkoxy or trifluoromethyl radical; R2 is an alkyl radical; saturated cycloalkyl; heterocycloalkyl optionally N-substituted; phenyl optionally substituted with 1, 2 or 3 identical or different substituents selected from fluorine, chlorine, bromine, amino, acetamido, nitro, methyl, trifluoromethyl and methoxy; arylalkyl consisting of an alkyl group substituted by a phenyl radical optionally substituted by 1, 2 or 3 of the aforementioned substituents; heteroaryl or of fused heteroaromatic system optionally substituted by 1, 2 or 3 of the aforementioned substituents; and heteroarylalkyl consisting of an alkyl group substituted with a heteroaryl radical or fused heteroaromatic system optionally substituted by 1, 2 or 3 of the aforementioned substituents; and their physiologically acceptable salts. The compounds have sedative, anticonvulsant, analgesic, muscular relaxant, antitusigenic, ansiolytic, antipsycotic, antidepressant, anti-cerebral ischeamic, anti-migraine activity and are useful in the treatment of sleep disorders, neurodegenerative diseases, cognitive disorders, Alzheimer's disease, sleep-inducing or as general anaesthetic agents.
Patent NZ-505696-A (NZ)
Title: Antibodies against human CD40
Inventor: ARUFFO ALEJANDRO A
IPC: C12N15/09
Filed: 1999-02-10
Abstract: A novel chimeric and humanized anti-human CD40 antibodies which block the interaction between gp39 and CD40. The anti-CD40 antibodies of the present invention are effective in modulating humoral immune responses against T cell dependent antigen, collagen induced arthiritis, and skin transplantation and are also useful for their anti-inflammatory properties.
Patent NZ-508230-A (NZ)
Title: Roadside control device for a toll apparatus installed in a motor vehicle
Inventor: WIDL ANDREAS
IPC: G07B15/06
Filed: 1999-05-26
Abstract: A roadside control device (1) for determining whether a toll apparatus (11) installed in a motor vehicle (10) passing the control device (1) and carrying an identifying licence plate (6) is functioning correctly. The toll apparatus (11) carries out an electronic, satellite-assisted toll deduction and is fitted with the following devices: a) a communication device (2), b) a classification device (3), a triggering device (4), d) an evaluation device (5) and e) a receiving device (7).